Entasis Therapeutics Holdings Inc. | Business Contracts

Form of Retention Bonus Award Memo (Filed With SEC on March 3, 2022)

Registration Rights Agreement, dated February 18, 2022 by and between the Company and Innoviva (Filed With SEC on February 18, 2022)

Second Amended Non-Employee Director Compensation Policy, as amended January 1, 2022 (Filed With SEC on March 3, 2022)

Amendment to Stock Option Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Amendment to Restricted Stock Unit Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Amended Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Amended Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)

Securities Purchase Agreement, dated February 17, 2022, by and between the Company and Innoviva (Filed With SEC on February 18, 2022)

Form of Warrant Certificate (Filed With SEC on February 18, 2022)

Convertible Promissory Note, dated February 18, 2022 (Filed With SEC on February 18, 2022)

Form of Registration Rights Agreement (Filed With SEC on May 3, 2021)

Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva (Filed With SEC on May 3, 2021)

Form of Warrant Certificate (Filed With SEC on May 3, 2021)

Form of Restricted Stock Unit Grant Notice (Time-Based) (Filed With SEC on November 6, 2020)

Form of Restricted Stock Unit Grant Agreement (Filed With SEC on November 6, 2020)

Form of Restricted Stock Unit Grant Notice (Performance-Based) (Filed With SEC on November 6, 2020)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)

First Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 6, 2020)

Special Bonus Award Memorandum, dated May 15, 2020 (Filed With SEC on August 6, 2020)

Amended Non-employee Director Compensation Policy, as amended December 6, 2019 (Filed With SEC on August 6, 2020)

Non-employee Director Compensation Policy, as amended June 19, 2019 (Filed With SEC on May 7, 2020)

Employment Agreement between the Company and Eric Kimble, effective September 6, 2019 (Filed With SEC on May 7, 2020)

Form of Executive Officer Employment Agreement (Filed With SEC on May 7, 2020)

Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)

Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)

Form of Investor Rights Agreement (Filed With SEC on April 13, 2020)

Form of Voting Agreement (Filed With SEC on April 13, 2020)

Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva (Filed With SEC on April 13, 2020)

Form of Registration Rights Agreement (Filed With SEC on April 13, 2020)

Form of Warrant Certificate (Filed With SEC on April 13, 2020)

Non-Employee Director Compensation Policy (Filed With SEC on March 11, 2020)

Employment Agreement between the Company and Ruben Tommasi, effective September 25, 2018 (Filed With SEC on March 29, 2019)

Entasis Therapeutics Holdings Inc. (44)